June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
MCP-1 disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium
Author Affiliations & Notes
  • Hidetaka Noma
    Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
    Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, United States
  • Kevin McDonald
    Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, United States
  • Masahiko Shimura
    Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
  • Shigeo Tamiya
    Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, United States
  • Footnotes
    Commercial Relationships   Hidetaka Noma, None; Kevin McDonald, None; Masahiko Shimura, None; Shigeo Tamiya, None
  • Footnotes
    Support  Research to Prevent Blindness NY, NY; KY LIONS EYE FOUNDATION
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 598. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Hidetaka Noma, Kevin McDonald, Masahiko Shimura, Shigeo Tamiya; MCP-1 disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2017;58(8):598.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal pigment epithelial (RPE) cells form the blood-ocular barrier, and their polarized property is crucial for maintaining the barrier function. Loss of RPE barrier function is associated with variety of ocular disorders. The expression of monocyte chemoattractant protein (MCP)-1, an inflammatory cytokine, is increased in several diseases in which RPE barrier function is likely disrupted. We hypothesized that MCP-1 is involved in this process, and the purpose of this study was to investigate the effects of MCP-1 on the barrier function of polarized RPE cells.

Methods : Isolated porcine RPE cells were seeded on Transwell™ membranes. Transepithelial electrical resistance (TER) was measured using EVOM (WPI). Polarized RPE (TER >150 Ω cm2) cells were incubated with 10 ng/ml or 20 ng/ml of MCP-1 and the TER was measured. The sites of the tight junction-associated molecules ZO-1, claudin-19, and F-actin were determined immunohistochemically.

Results : MCP-1 significantly decreased the TER of polarized RPE cells in both 10 ng/ml and 20 ng/ml compared to controls at 24 hours. Immunohistochemical staining revealed that claudin-19 located between cells in control RPE cells was disassembled by MCP-1. Interestingly, in contrast, ZO-1 remained intact in the presence of MCP-1.

Conclusions : These findings suggest that MCP-1 can breakdown RPE barrier function in polarized RPEs by disassembling claudin-19. MCP-1, therefore, might play an important role in ocular disorders with disrupted barrier function.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×